Peo in Interest of SRW

CourtColorado Court of Appeals
DecidedMarch 19, 2026
Docket25CA1985
StatusUnpublished

This text of Peo in Interest of SRW (Peo in Interest of SRW) is published on Counsel Stack Legal Research, covering Colorado Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Peo in Interest of SRW, (Colo. Ct. App. 2026).

Opinion

25CA1985 Peo in Interest of SRW 03-19-2026

COLORADO COURT OF APPEALS

Court of Appeals No. 25CA1985 Pueblo County District Court No. 25MH30093 Honorable Amiel Markenson, Judge

The People of the State of Colorado,

Petitioner-Appellee,

In the Interest of S.R.W.,

Respondent-Appellant.

ORDER AFFIRMED

Division II Opinion by JUDGE FOX Kuhn and Sullivan, JJ., concur

NOT PUBLISHED PURSUANT TO C.A.R. 35(e) Announced March 19, 2026

Cynthia Mitchell, County Attorney, Kate H. Shafer, Special Assistant County Attorney, Pueblo, Colorado, for Appellee

Tezak Law, P.C., Mary Tezak, Florence, Colorado, for Respondent-Appellant ¶1 S.R.W. appeals the district court’s order authorizing staff at

the Colorado Mental Health Hospital in Pueblo (the hospital) to

medicate him without his consent. We affirm.

I. Background

¶2 S.R.W. was admitted to the hospital in September 2025 after

being found incompetent to proceed in two criminal cases. His

symptoms included delusions and paranoia — as well as believing

that numerous unrelated people were conspiring against him — and

behaving in impulsive, agitated, and threatening ways. His

psychiatrist at the hospital, Dr. Hareesh Pillai, diagnosed him with

psychosis (not otherwise specified). After an incident in which

S.R.W. postured toward staff members with closed fists, threatened

to kill them, spit at them after he was restrained, and bit one of

them, he was given emergency medications.

¶3 The State petitioned the district court for authorization to

medicate S.R.W. involuntarily with two antipsychotic medications —

Zyprexa (olanzapine) and Thorazine (chlorpromazine) — and the

mood-stabilizing medication Depakote (valproic acid).

¶4 At the hearing on the petition, Dr. Pillai and S.R.W. testified.

Dr. Pillai, whom the parties stipulated is an expert in clinical

1 psychiatry, testified that S.R.W.’s psychosis constitutes a

substantial disorder that grossly impairs his judgment or capacity

to recognize reality or to control his behavior. Dr. Pillai testified

that S.R.W. needs psychiatric medications and has already shown

improvement on the requested medications; however, the doctor

reported that S.R.W. doesn’t believe he has a psychiatric illness or

needs medication. Dr. Pillai opined that without the requested

medications, S.R.W. will experience a significant and likely long-

term deterioration of his mental condition and will pose a risk of

serious harm to others in the hospital. Finally, the doctor testified

that S.R.W. has reported experiencing multiple side effects from the

medications and that using them is against his religion.

¶5 S.R.W. testified that he does not have a mental illness, is not a

danger to others, and will not take medications voluntarily. He

testified that his religion — the Ausar Auset Society — forbids him

from taking medication, while clarifying on cross-examination that

it forbids mind-altering medication. He also testified about various

side effects he has experienced from the medications, including

drowsiness, dizziness, fatigue, drooling, urinary incontinence,

testicular pain, difficulty sleeping, and inability to focus.

2 ¶6 Following the testimony, the district court found that Dr.

Pillai’s testimony was credible and persuasive, and it adopted his

opinions. The court then examined each of the four elements of the

test from People v. Medina, 705 P.2d 961, 973 (Colo. 1985),

concluded that the State had met its burden of proving all four

elements, and granted the petition.

II. Applicable Law and Standard of Review

¶7 The parties agree that the Medina test applies here. Under

that test, a district court may authorize the involuntary

administration of medication if the State demonstrates by clear and

convincing evidence that

(1) the patient is incompetent to effectively participate in the

treatment decision;

(2) the treatment is necessary to prevent a significant and

likely long-term deterioration in the patient’s mental health

condition or to prevent the likelihood of the patient causing

serious harm to himself or others in the institution;

(3) a less intrusive treatment alternative is not available; and

3 (4) the patient’s need for treatment is sufficiently compelling to

override any bona fide and legitimate interest of the patient in

refusing treatment.1

Id.

¶8 Application of the Medina test involves mixed questions of fact

and law. People v. Marquardt, 2016 CO 4, ¶ 8. We defer to the

district court’s factual findings if they have record support, while we

review the court’s legal conclusions de novo. Id. Resolving conflicts

in testimony and determining the credibility of the witnesses are

matters solely within the province of the district court. People in

Interest of Ramsey, 2023 COA 95, ¶ 23.

III. Analysis

¶9 S.R.W. expressly does not contest the district court’s rulings

that the State met its burden of proving the second and third

Medina elements.

1 A different test applies to petitions to administer medication

involuntarily for the purpose of restoring a defendant’s competency in a criminal case. See People in Interest of R.F., 2019 COA 110, ¶¶ 10-15 & n.1 (discussing the test from Sell v. United States, 539 U.S. 166, 180 (2003)).

4 ¶ 10 As to the first Medina element, S.R.W. initially argues in his

opening brief that “the People failed to establish the first and fourth

[Medina] elements by clear and convincing evidence.” However, in

specifically addressing the first Medina element, S.R.W. says only

that “[t]his element is uncontested.” Because S.R.W. does not

present any specific argument challenging the district court’s ruling

on the first Medina element, we will not address it. See C.A.R.

28(a)(7)(B); People in Interest of C.N., 2018 COA 165, ¶ 44.

¶ 11 We now turn to the fourth Medina element, the only element

that S.R.W. specifically challenges on appeal. He contends that the

evidence was insufficient to show that his need for the medications

is sufficiently compelling to override his bona fide and legitimate

interests in not taking them.

¶ 12 In analyzing the fourth Medina element, a court first

determines “whether the patient’s refusal is bona fide and

legitimate.” Medina, 705 P.2d at 974. If it is, the court then

determines “whether the prognosis without treatment is so

unfavorable that the patient’s personal preference must yield to the

legitimate interests of the state in preserving the life and health of

5 the patient placed in its charge and in protecting the safety of those

in the institution.” Id.

¶ 13 In a sufficiency challenge, we must determine whether the

evidence, viewed as a whole and in the light most favorable to the

State, is sufficient to support the district court’s order. People in

Interest of R.K.L., 2016 COA 84, ¶ 13. The testimony of the

physician seeking to administer treatment may be sufficient,

without more, to satisfy the Medina test. R.K.L., ¶ 30.

¶ 14 In terms of S.R.W.’s interests in not taking the medications,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sell v. United States
539 U.S. 166 (Supreme Court, 2003)
People v. Medina
705 P.2d 961 (Supreme Court of Colorado, 1985)
People v. Marquardt
2016 CO 4 (Supreme Court of Colorado, 2016)
People ex rel. R.K.L
2016 COA 84 (Colorado Court of Appeals, 2016)
in the Interest of C.N
2018 COA 165 (Colorado Court of Appeals, 2018)
in Interest of R.F
2019 COA 110 (Colorado Court of Appeals, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Peo in Interest of SRW, Counsel Stack Legal Research, https://law.counselstack.com/opinion/peo-in-interest-of-srw-coloctapp-2026.